Published by Iain Gilbert on 21st September 2026
(Sharecast News) - Drugmaker Astrazeneca received a double boost on Monday as European regulators issued positive opinions for two of its medicines - Klygefa for generalised myasthenia gravis and Enhertu for early‑stage HER2‑positive breast cancer.
URL: http://www.digitallook.com/dl/news/story/36223178/...